Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice.

Christopher M GallagherKenneth MoreAnthony MasaquelTripthi KamathAnnie GuerinRaluca Ionescu-IttuRoy NitulescuMarjolaine Gauthier-LoiselleNicholas SicignanoElizabeth ButtsEric Q WuBrian Barnett

Published in: SpringerPlus (2016)

OS rates estimated in this study were in range with those estimated in the B-31/N9831 trials, while RFS rates were lower. However, patients in the B-31/N9831 trials were younger and possibly had fewer comorbidities than patients in the current study; these differences were not adjusted for in the crude OS and RFS analyses.

Keyphrases

end stage renal disease
newly diagnosed
metastatic breast cancer
ejection fraction
chronic kidney disease
clinical practice
peritoneal dialysis
early stage
patient reported outcomes
patient reported
free survival